<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02447081</url>
  </required_header>
  <id_info>
    <org_study_id>SJM-CIP-10053</org_study_id>
    <nct_id>NCT02447081</nct_id>
  </id_info>
  <brief_title>Amplatzer™Amulet™ Post-Market Study (Amulet™PMS)</brief_title>
  <acronym>Amulet™PMS</acronym>
  <official_title>Amplatzer™Amulet™ Observational Post-Market Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Medical Devices</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This was a prospective, multicenter, observational, nonrandomized study to compile real world
      outcome data on the use of the Amulet™ device in non-valvular atrial fibrillation (NVAF)
      subjects. The study was designed to follow the Instructions For Use (IFU) to gather data on
      the implant procedure through two years of follow up with the Amulet™ device in a commercial
      clinical setting.&quot;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 1088 subjects were enrolled in the study at 61 sites internationally, outside the
      United States.

      The study assessed acute and late serious adverse events and reports the rate of stroke and
      bleeding events through 2 years. No formal hypothesis were tested for this observational
      post-market study.

      Each patient was followed at study visits at baseline, implant, 1-3 months, 6 months, 12
      months, and 24 months post implant.&quot;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2015</start_date>
  <completion_date type="Actual">October 23, 2018</completion_date>
  <primary_completion_date type="Actual">October 23, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Number of Participants With Acute Serious Adverse Events</measure>
    <time_frame>0 to 7 days post procedure</time_frame>
    <description>Acute adverse events were defined as those serious events with an onset date ≤ 7 days post-procedure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Late Serious Adverse Events Greater Than 7 Days Post Procedure</measure>
    <time_frame>7 days through 2 years</time_frame>
    <description>Late adverse events were defined as those serious events with an onset date &gt; 7 days post-procedure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Ischemic Stroke, Systemic Embolism and Cardiovascular Death</measure>
    <time_frame>Implant through 2 years</time_frame>
    <description>Occurrence of ischemic stroke, systemic embolism, and cardiovascular death through 2 years</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Major Bleeding Events</measure>
    <time_frame>Implant through 2 years</time_frame>
    <description>Clinical events were adjudicated by the CEC as major bleeding events if they met the definition of Type 3 or greater on the Bleeding Academic Research Consortium (BARC) scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Technical Success</measure>
    <time_frame>During implant procedure, approximately 30 to 60 minutes</time_frame>
    <description>Technical success is defined as successful implantation of the Amulet device in the left arterial appendage (LAA).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Procedural Success</measure>
    <time_frame>During the implant procedure and hospital stay, approximately 1 or 2 days</time_frame>
    <description>Procedural success is based on Amulet device being implanted day 0 through hospital discharge, on average one night stay (day 1). Amulet device implanted and subject discharged the following day without an adverse event</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Oral Anti-coagulation Usage</measure>
    <time_frame>At discharge, approximately 1 or 2 days after the procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Oral Anti-coagulation Usage</measure>
    <time_frame>At 1 to 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Oral Anti-coagulation Usage</measure>
    <time_frame>At 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Oral Anti-coagulation Usage</measure>
    <time_frame>At 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Oral Anti-coagulation Usage</measure>
    <time_frame>At 24 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1088</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Thromboembolism</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Subjects implanted with Amulet Device</arm_group_label>
    <description>All subjects who receive the Amulet device will be followed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Subjects implanted with Amulet Device</intervention_name>
    <description>Percutaneous Left Atrial Appendage occlusion with successful implant of occlusion device.</description>
    <arm_group_label>Subjects implanted with Amulet Device</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with non-valvular atrial fibrillation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject with history of paroxysmal, persistent or permanent NVAF

          2. Subject who is 18 years or older, or of legal age to give informed consent specific to
             state and national law

          3. Subject who is eligible for an Amulet LAA Occluder device according to current
             international guidelines and per physician discretion

          4. Subject who is willing and capable of providing informed consent, participating in all
             associated study activities

        Exclusion Criteria:

          1. Subject with evidence of an intracardiac thrombus

          2. Subject with active infection or active endocarditis or other infections producing
             bacteremia

          3. Subject where the placement of the device would interfere with any intracardiac or
             intravascular structures

          4. Subject with any medical disorder that would interfere with completion or evaluation
             of clinical study results

          5. Women of childbearing potential who are, or plan to become, pregnant during the time
             of the study (method of assessment per physician discretion)

          6. Subject with LAA anatomy that does not accommodate a device per the sizing guidelines
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Hildick-Smith, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brighton and Sussex University Hospitals</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claudio Tondo, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Milan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fiona Stanley Hospital</name>
      <address>
        <city>Murdoch</city>
        <state>Western Australia</state>
        <zip>WA 6150</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaire Ziekenhuizen Gasthuisberg</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico San Borja Arriaran</name>
      <address>
        <city>Santiago</city>
        <zip>83600160</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <state>Uusimaa</state>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Haut Leveque</name>
      <address>
        <city>Pessac</city>
        <state>Aquitaine</state>
        <zip>33600</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU du Bocage</name>
      <address>
        <city>Dijon</city>
        <state>Burgundy</state>
        <zip>21034</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Lille</name>
      <address>
        <city>Lille</city>
        <state>North-Calais</state>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU d'Amiens</name>
      <address>
        <city>Amiens</city>
        <state>Picardy</state>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Coburg</name>
      <address>
        <city>Coburg</city>
        <state>Bavaria</state>
        <zip>96450</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Internistische Klinik Dr. Müller, München-Thalkirchen</name>
      <address>
        <city>Muenchen</city>
        <state>Bavaria</state>
        <zip>81379</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Ulm</name>
      <address>
        <city>Ulm</city>
        <state>Bavaria</state>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zentrum fur Herzgesundheit/Kardiologie am Alice Hospital Darmstadt</name>
      <address>
        <city>Darmstadt</city>
        <state>Hesse</state>
        <zip>64287</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CardioVaskuläres Centrum St. Katharinen</name>
      <address>
        <city>Frankfurt</city>
        <state>Hesse</state>
        <zip>60389</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Düsseldorf</name>
      <address>
        <city>Duesseldorf</city>
        <state>North Rhine-Westphal</state>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zentralklinik Bad Berka Gmbh</name>
      <address>
        <city>Bad Berka</city>
        <state>Thuringia</state>
        <zip>99437</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zentralklinik Bad Berka</name>
      <address>
        <city>Bad Berka</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Segeberger Kliniken Gmbh</name>
      <address>
        <city>Bad Segeberg</city>
        <zip>23795</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Segeberger Kliniken GmbH</name>
      <address>
        <city>Bad Segeberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin (CBF)</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Marien Hospital Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53115</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Dresden</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardioangiologisches Centrum Bethanien</name>
      <address>
        <city>Frankfurt</city>
        <zip>60431</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Frankfurt Höchst</name>
      <address>
        <city>Frankfurt</city>
        <zip>65929</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harzklinikum Dorothea Christiane Erxleben GmbH</name>
      <address>
        <city>Quedlinburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rems-Murr-Klinikum Winnenden</name>
      <address>
        <city>Winnenden</city>
        <zip>71364</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mater Hospital</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Chaim Sheba Medical Center</name>
      <address>
        <city>Tel Hashomer</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nuovo Ospedale Civile Sant'Agostino Estense</name>
      <address>
        <city>Baggiovara, 1355</city>
        <state>Modena</state>
        <zip>41126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale dell'Angelo and Ospedale SS Giovanni e Paolo Venezia</name>
      <address>
        <city>Mestre</city>
        <state>Veneto</state>
        <zip>30174</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Università degli Studi di Padova</name>
      <address>
        <city>Padova</city>
        <state>Veneto</state>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera S. Anna e S. Sebastiano</name>
      <address>
        <city>Caserta</city>
        <zip>81100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale del Cuoro Fondazione C. N. R. Regione Toscana G. Monasterio</name>
      <address>
        <city>Massa</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Luigi Sacco</name>
      <address>
        <city>Milano</city>
        <zip>20157</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiac Arrhythmia Research Center, Centro Cardiologico Monzino, Unveristiy of Milan</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Raffaele Hospital</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amsterdam Academic Medical Centre</name>
      <address>
        <city>Veenendaal</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ulleval Universitetssykehus</name>
      <address>
        <city>Oslo</city>
        <zip>0407</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Cardinal Stefan Wyszynski Institute of Cardiology</name>
      <address>
        <city>Warsaw</city>
        <zip>04-628</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Slaskie Centrum Chorob Serca</name>
      <address>
        <city>Warszawa</city>
        <zip>01-785</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <state>Andalusia</state>
        <zip>41007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Son Espases</name>
      <address>
        <city>Palma de Mallorca</city>
        <state>Balearic Island</state>
        <zip>07120</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <state>Castile And Leon</state>
        <zip>37007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu I Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <state>Catalonia</state>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Infanta Cristina</name>
      <address>
        <city>Badajoz</city>
        <state>Extremadura</state>
        <zip>6080</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic I Provincial de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>8028</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital Huddinge</name>
      <address>
        <city>Stockholm</city>
        <zip>17176</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Liverpool Heart and Chest Hospital</name>
      <address>
        <city>Liverpool</city>
        <state>Northwest England</state>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Royal Sussex Country Hospital</name>
      <address>
        <city>Brighton</city>
        <state>South East England</state>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Thomas Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Belgium</country>
    <country>Chile</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Ireland</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>April 27, 2015</study_first_submitted>
  <study_first_submitted_qc>May 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 18, 2015</study_first_posted>
  <results_first_submitted>November 1, 2019</results_first_submitted>
  <results_first_submitted_qc>December 11, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">December 30, 2019</results_first_posted>
  <last_update_submitted>December 11, 2019</last_update_submitted>
  <last_update_submitted_qc>December 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Thromboembolism</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 21, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/81/NCT02447081/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>A total of 1088 subjects were enrolled and attempted implant with Amulet left atrial appendage occluder conducted at 61 sites between June 01, 2015 and September 19, 2016. The final study visit at 2 years post-implant was completed by 864 subjects, with the last study visit occurring in October 2018.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Subjects Implanted With Amulet Device</title>
          <description>Subjects implanted with Amulet Device: Percutaneous Left Atrial Appendage occlusion with successful implant of occlusion device.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1088"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="864"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="224"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="161"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Visit not completed</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>unsuccessful implant procedure</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Subjects Implanted With Amulet Device</title>
          <description>All subjects who received the Amulet device were followed.
Subjects implanted with Amulet Device: Percutaneous Left Atrial Appendage occlusion with successful implant of occlusion device.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1088"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="122"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="966"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75.2" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="386"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="702"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Spain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Netherlands</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sweden</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Belgium</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Norway</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Finland</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Poland</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Denmark</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Italy</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="178"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Israel</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Australia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>France</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chile</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="378"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hong Kong</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Switzerland</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1088"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Acute Serious Adverse Events</title>
        <description>Acute adverse events were defined as those serious events with an onset date ≤ 7 days post-procedure</description>
        <time_frame>0 to 7 days post procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subjects Implanted With Amulet Device</title>
            <description>All subjects who received the Amulet device were followed.
Subjects implanted with Amulet Device: Percutaneous Left Atrial Appendage occlusion with successful implant of occlusion device.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Acute Serious Adverse Events</title>
          <description>Acute adverse events were defined as those serious events with an onset date ≤ 7 days post-procedure</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1088"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Late Serious Adverse Events Greater Than 7 Days Post Procedure</title>
        <description>Late adverse events were defined as those serious events with an onset date &gt; 7 days post-procedure</description>
        <time_frame>7 days through 2 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subjects Implanted With Amulet Device</title>
            <description>All subjects who received the Amulet device were followed.
Subjects implanted with Amulet Device: Percutaneous Left Atrial Appendage occlusion with successful implant of occlusion device.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Late Serious Adverse Events Greater Than 7 Days Post Procedure</title>
          <description>Late adverse events were defined as those serious events with an onset date &gt; 7 days post-procedure</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1088"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="504"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Ischemic Stroke, Systemic Embolism and Cardiovascular Death</title>
        <description>Occurrence of ischemic stroke, systemic embolism, and cardiovascular death through 2 years</description>
        <time_frame>Implant through 2 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subjects Implanted With Amulet Device</title>
            <description>All subjects who received the Amulet device were followed.
Subjects implanted with Amulet Device: Percutaneous Left Atrial Appendage occlusion with successful implant of occlusion device.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Ischemic Stroke, Systemic Embolism and Cardiovascular Death</title>
          <description>Occurrence of ischemic stroke, systemic embolism, and cardiovascular death through 2 years</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1088"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Major Bleeding Events</title>
        <description>Clinical events were adjudicated by the CEC as major bleeding events if they met the definition of Type 3 or greater on the Bleeding Academic Research Consortium (BARC) scale.</description>
        <time_frame>Implant through 2 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subjects Implanted With Amulet Device</title>
            <description>All subjects who received the Amulet device were followed.
Subjects implanted with Amulet Device: Percutaneous Left Atrial Appendage occlusion with successful implant of occlusion device.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Major Bleeding Events</title>
          <description>Clinical events were adjudicated by the CEC as major bleeding events if they met the definition of Type 3 or greater on the Bleeding Academic Research Consortium (BARC) scale.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1088"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Technical Success</title>
        <description>Technical success is defined as successful implantation of the Amulet device in the left arterial appendage (LAA).</description>
        <time_frame>During implant procedure, approximately 30 to 60 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subjects Implanted With Amulet Device</title>
            <description>All subjects who received the Amulet device were followed.
Subjects implanted with Amulet Device: Percutaneous Left Atrial Appendage occlusion with successful implant of occlusion device.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Technical Success</title>
          <description>Technical success is defined as successful implantation of the Amulet device in the left arterial appendage (LAA).</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1088"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1078"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Procedural Success</title>
        <description>Procedural success is based on Amulet device being implanted day 0 through hospital discharge, on average one night stay (day 1). Amulet device implanted and subject discharged the following day without an adverse event</description>
        <time_frame>During the implant procedure and hospital stay, approximately 1 or 2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subjects Implanted With Amulet Device</title>
            <description>All subjects who received the Amulet device were followed.
Subjects implanted with Amulet Device: Percutaneous Left Atrial Appendage occlusion with successful implant of occlusion device.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Procedural Success</title>
          <description>Procedural success is based on Amulet device being implanted day 0 through hospital discharge, on average one night stay (day 1). Amulet device implanted and subject discharged the following day without an adverse event</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1088"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1039"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Oral Anti-coagulation Usage</title>
        <time_frame>At discharge, approximately 1 or 2 days after the procedure</time_frame>
        <population>The number of participates completing a study visit at the Time Frame</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Implanted With Amulet Device</title>
            <description>All subjects who received the Amulet device were followed.
Subjects implanted with Amulet Device: Percutaneous Left Atrial Appendage occlusion with successful implant of occlusion device.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Oral Anti-coagulation Usage</title>
          <population>The number of participates completing a study visit at the Time Frame</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1074"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>OAC without anti-platelet therapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>OAC with antiplatelet therapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Oral Anti-coagulation Usage</title>
        <time_frame>At 1 to 3 months</time_frame>
        <population>The number of participates completing a study visit at the Time Frame</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Implanted With Amulet Device</title>
            <description>All subjects who received the Amulet device were followed.
Subjects implanted with Amulet Device: Percutaneous Left Atrial Appendage occlusion with successful implant of occlusion device.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Oral Anti-coagulation Usage</title>
          <population>The number of participates completing a study visit at the Time Frame</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1018"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>OAC without anti-platelet therapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>OAC with anti-platelet therapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Oral Anti-coagulation Usage</title>
        <time_frame>At 6 months</time_frame>
        <population>The number of participates completing a study visit at the Time Frame</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Implanted With Amulet Device</title>
            <description>All subjects who received the Amulet device were followed.
Subjects implanted with Amulet Device: Percutaneous Left Atrial Appendage occlusion with successful implant of occlusion device.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Oral Anti-coagulation Usage</title>
          <population>The number of participates completing a study visit at the Time Frame</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1009"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>OAC without anti-platelet therapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>OAC with anti-platelet therapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Oral Anti-coagulation Usage</title>
        <time_frame>At 12 months</time_frame>
        <population>The number of participates completing a study visit at the Time Frame</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Implanted With Amulet Device</title>
            <description>All subjects who received the Amulet device were followed.
Subjects implanted with Amulet Device: Percutaneous Left Atrial Appendage occlusion with successful implant of occlusion device.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Oral Anti-coagulation Usage</title>
          <population>The number of participates completing a study visit at the Time Frame</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="950"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>OAC without anti-platelet therapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>OAC with anti-platelet therapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Oral Anti-coagulation Usage</title>
        <time_frame>At 24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subjects Implanted With Amulet Device</title>
            <description>All subjects who received the Amulet device were followed.
Subjects implanted with Amulet Device: Percutaneous Left Atrial Appendage occlusion with successful implant of occlusion device.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Oral Anti-coagulation Usage</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="864"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>OAC without anti-platelet therapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>OAC with anti-platelet therapy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 years</time_frame>
      <desc>Non-serious adverse event information was not analyzed.</desc>
      <group_list>
        <group group_id="E1">
          <title>Subjects Implanted With Amulet Device</title>
          <description>All subjects who received the Amulet device were followed.
Subjects implanted with Amulet Device: Percutaneous Left Atrial Appendage occlusion with successful implant of occlusion device.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (10.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="161" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="538" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemias</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Bleeding</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Leukemias</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Melena</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute bacterial endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Aortic value stenosis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Arterial hypertension/Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="37" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Atrioventricular dissociation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Cardiac Arrest</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Cardiac Decompensation</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Cardiac Perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Cardiogenic Shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Congestive Heart Failure</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Coronary Artery Disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Decompensated Heart Failure</sub_title>
                <counts group_id="E1" subjects_affected="62" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>EKG Abnormalities</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Heart Block</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Heart Failure</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hemiblock (Fascicular Block)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Ischemic Stroke</sub_title>
                <counts group_id="E1" subjects_affected="39" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Mitral Valve Regurgitation/Mitral Insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Paroxysmal Atrial Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Pericardial Tamponade</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Peripheral Arterial Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Peripheral Vascular Disease</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Persistent Atrial Fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Right Ventricular Failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Second Degree Heart Block</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Sick Sinus Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Sinus Bradycardia/Sinus Bradycardia (Cardiac Arrhythmia)</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Sustained Atrial Fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>TEE-Related Event</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Third Degree Heart Block (Complete Heart Block)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Thrombus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Thrombus on Device</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Torsade de Pointes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Tricuspid Regurgitation/Tricuspid Insufficiency/Valvular Regurgitation Valve</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Unstable Angina</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Unsustained/Nonsustained Ventricular Tachy/Cardiac Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Vascular Dissection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Vascular Ischemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Ventricular Fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Ventricular Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Osler Weber Rendu Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetes Mellitus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Eye Bleed</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Ocular Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Acute erosive gastritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Acute pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Aspiration Pneumonia/Necrotizing pneumonia/Aspiration of vomitus</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Benign Tumors</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Bowel Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Diverticulosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Duodenal Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Emesis/Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Bleeding</sub_title>
                <counts group_id="E1" subjects_affected="57" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Gastroparesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Heartburn</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hematemesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hematochezia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hemoperitoneum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Inguinal Hernia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Iron-Deficiency Anemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Perforated Appendix</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chronic Renal Failure</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Confusion</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Drug Side Effect</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hypokalemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hypothermia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Multiple Organ Failure</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Non-Cardiac Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Shock</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Transient Ischemic Attack (TIA)</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Trauma</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Weakness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Wound Dehiscence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Other</sub_title>
                <counts group_id="E1" subjects_affected="50" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Choledocholithiaisis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hepatic and Biliary Disorders</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Primary Biliary Cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Bacterial infections of the skin</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Clostridum difficile Infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Fungal Skin Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Infective/Bacterial Endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Miscellaneous Infections</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Septicemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Viral Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Alcohol intoxication</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Burns</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Compression Fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Fever</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Respiratory Failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>VASC Pseudoaneurysm</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hypercalcemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hyperkalemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hypoglycemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arm fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hip Dislocation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hip Fracture</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hip Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Knee Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Low Back Pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Lumbar Spondylosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Osteoarthritis/Degenerative Joint Disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Rheumotologic Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Spinal Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Breast Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Cancer</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Colon Cancer</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Lung Cancer</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Melanoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Pancreatic Cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Skin Cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Acute subdural hematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Brain Tumor</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Cerebral Aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Chronic Subdural Hematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Generalized Seizures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Intracerebral Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Neurological Hematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Parkinson's Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Polyneuropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Portal-Systemic Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Seizure/Convulsions/Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Simple Partial Seizures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Status Epilepticus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Subdural Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Vaso Vagal Response</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Cognitive Impairment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hallucinations</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Psychogenic Event</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Suicide Attempt</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Acute renal failure</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hematuria</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Renal Insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Urethral Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infections</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Acute pulmonary edema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Adult respiratory distress syndrome(ARDS)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Air embolus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Chronic Obstructive Pulmonary Disease (COPD)</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hypoventilation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="33" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Pneumonia Caused By Gram-Negative Bacilli</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Pneumonia in the Compromised Host</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Pulmonary Edema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Cutaneous Abcesses</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Pressure Sores</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Skin Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Device Embolization</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Elective Cardiac Surgery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>VASC AV Fistula</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep Vein/Venous Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Hypertensive Crisis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Orthostatic Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Raynaud’s Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>VASC Bleeding</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>VASC Hematoma</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1088"/>
              </event>
              <event>
                <sub_title>Vessel Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1088"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ryan Gage, Senior Scientist</name_or_title>
      <organization>Abbott</organization>
      <phone>651 756 3334</phone>
      <email>Ryan.Gage@abbott.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

